SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Scien - Quaterly Results

19 May 2026 Evaluate
The Revenue for the quarter ended  March 2026 of Rs. 6057.35 millions grew by 8.95 % from Rs. 5559.58 millions.Profit for the quarter ended March 2026 grew by 1.40% to Rs. 163.53 millions from Rs. 161.28 millions.Operating Profit reported a sharp decline to 783.61 millions from 800.54 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 6057.35 5559.58 8.95 21801.35 21394.23 1.90 21801.35 21394.23 1.90
Other Income 39.70 121.22 -67.25 1230.63 461.88 166.44 1230.63 461.88 166.44
PBIDT 783.61 800.54 -2.11 4081.07 3086.30 32.23 4081.07 3086.30 32.23
Interest 266.62 293.60 -9.19 1137.68 1459.12 -22.03 1137.68 1459.12 -22.03
PBDT 516.99 506.94 1.98 2943.39 1626.91 80.92 2943.39 1626.91 80.92
Depreciation 251.91 223.71 12.61 912.38 846.08 7.84 912.38 846.08 7.84
PBT 265.08 283.23 -6.41 2031.01 780.83 160.11 2031.01 780.83 160.11
TAX 101.55 121.95 -16.73 194.66 189.27 2.85 194.66 189.27 2.85
Deferred Tax 45.23 174.31 -74.05 24.71 203.91 -87.88 24.71 203.91 -87.88
PAT 163.53 161.28 1.40 1836.35 591.56 210.42 1836.35 591.56 210.42
Equity 921.73 921.63 0.01 921.73 921.63 0.01 921.73 921.63 0.01
PBIDTM(%) 12.94 14.40 -10.16 18.72 14.43 29.76 18.72 14.43 29.76

Strides Pharma Scien Share Price

1111.10 4.00 (0.36%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: